The Single-Topic Workshop dates for 2021 are now confirmed!

We look forward to welcoming the ILCA community to this inaugural event in Paris, France on June 10-11, 2021.

Single Topic Workshop is about:

The past few years have seen significant changes in the management of liver cancer and the Single Topic Workshop initiative was established in recognition of the rapidly changing therapeutic landscape. Each STW will focus on a specific area in which recent developments have transformed the field of HCC. ILCA aims to provide delegates with state-of-the-art lectures delivered by leading experts and anticipate that these meetings will be of interest to all disciplines engaged in delivering care to patients with liver cancer.

Who should Attend?

Clinical and translational researchers, clinicians (primarily GI/hepatology), and industry representatives interested in HCC prevention, early detection or biomarkers. Talks may have Western focus (cirrhosis instead of HBV) although can interest delegates from Asia.

What to Expect

• Understand at-risk patients and current recommendations for HCC surveillance
• Identify barriers to HCC surveillance and potential strategies to improve surveillance effectiveness
• Describe proven as well as promising chemoprevention strategies for HCC in patients with cirrhosis

Meet the Chairs 

Dr. Amit Singal
STW Co-Chair
UT Southwestern Medical Center, USA

Dr. Tim Meyer
STW Co-Chair
UCL Cancer Institute, University College, UK


10 June 2020




13:00 – 13:15 Welcome & Introduction by the STW Co-chairs Tim Meyer & Amit Singal
13:15 – 13:40 Risk stratification biomarkers – are we close? Yujin Hoshida
13:40 – 14:05 Risk stratification after resection: Can we tailor surveillance for recurrence Eric Vibert
14:05 – 14:30 HCC chemoprevention: Current options and the horizon Tracey Simon
14:30- 15:00 Panel Discussion All
15:00 – 15:20 Coffee Break
15:20 – 15:45 Biomarkers for HCC diagnosis Josep M. Llovet
15:45 – 16:10 Biomarkers for HCC prognosis and treatment response Tim Meyer
16:10- 16:40 Panel Discussion All


11 June 2020




08:30 – 08:50 HCC surveillance – current recommendations and supporting evidence Maria Reig
08:50 – 09:10 HCC surveillance utilization and potential interventions Amit Singal
09:10 – 09:30 Limitations of HCC surveillance test effectiveness and alternative imaging Valerie Vilgrain
09:30 – 09:50 Precision screening for HCC: Is it possible and what do we need? Pierre Nahon
09:50 – 10:20 Panel Discussion All
10:20 – 10:40 Coffee Break
10:40 – 11:00 Phases of biomarker validation Jorge Marrero
11:00 – 11:20 Emerging serum biomarkers for early HCC detection Philip Johnson
11:20 – 11:40 cfDNA for early HCC detection Beatriz Minguez
11:40 – 12:10 Panel Discussion All
12:10 – 13:30 Lunch
13:30 – 13:50 Patient advocacy perspective Andrea Wilson
13:50 – 14:05 Bench to bedside: commercialization of biomarkers Jeff Winick
14:05 – 14:20 Bench to bedside: commercialization of biomarkers Marilyn Olson
14:20 – 14:30 Closing by the STW Co-chairs Tim Meyer & Amit Singal
The workshop will take place in Holiday Inn Paris – Porte De Clichy Hotel, which is located in Paris’ north-western gateway district at the centre of “Grand Paris” project, an area where many international companies and future Judicial Precinct are located.

ILCA warmly thanks all Partners for their unrestricted support to the Single-Topic Workshop and their commitment to help advance liver cancer science.

If your organisation wishes to partner with ILCA and take part in the Single-Topic Workshop, please contact Rik Bollaert at [email protected] for sponsorship and exhibition opportunities. For media partnership, please contact Rebecka Larsson at [email protected].

For more information download the Partnership Opportunities Brochure

Meet some of the speakers


Here are a few of the confirmed speakers for the Single Topic Workshop this year. Keep updated as there are more to be announced!